Results of a national survey on ethacizine for atrial fibrillation treatment in real practice as a part of a patient oriented approach

12 April 2026 (08:00 - 15:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Professor Nataliia Sydorova

Ukrainian Military-Medical Academy (UMMA), Kiev (Ukraine)

5 More presentations in this session

Presentation thumbnail

Effect of sodium-glucose cotransporter 2 inhibitors (SGLT2) on the occurrence of tachyarrhythmias in patients with heart failure with reduced ejection fraction

Doctor J. Serrano Silva (Jerez de la Frontera, ES)

Abstract Slides Video

Presentation thumbnail

The influence of digoxin on outcomes in remotely monitored patients with implantable cardioverter-defibrillators

Doctor M. Dyrbus (Zabrze, PL)

Abstract Slides Video

Presentation thumbnail

Flecainide in the treatment of high premature ventricular contractions burden: preliminary results from the UNIFLECA study

Doctor S. Kotoulas (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Can colchicine tame atrial fibrillation? A scoping review

Miss S. Hasan (Coventry, GB)

Abstract Slides Video

Presentation thumbnail

Comparative outcomes of amiodarone and dronedarone in atrial fibrillation: a real-world retrospective cohort study

Doctor A. Akuka (Holon, IL)

Abstract Slides Video

Access the full session

Session thumbnail

Antiarrhythmic drugs

The Event

Event poster

EHRA 2026

12 April - 14 April 2026

You may be interested in

Congress Presentation

Current status of antiarrhythmic therapy in atrial fibrillation

Congress Presentation

Anti-arrhythmic drugs for prevention of atrial tachycardia following atrial fibrillation ablation: is this strategy obsolete?

Congress Session

Late-Breaking Science: ablation and drug therapy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources